OSI Pharmaceuticals, Inc.Melville, NY United States
Company Description
Fighting disease in small ways is what OSI Pharmaceuticals is all about. The company focuses on small molecule cures for diseases like cancer, allowing for treatment by pill rather than IV infusion. Its top seller Tarceva treats non-small cell lung cancer and pancreatic cancer and is in development for other indications as well. Partner
| 41 Pinelawn Rd. | Phone: 631-962-2000 | http://www.osip.com |
| Melville, NY 11747 | Fax: 631-752-3880 | |
| United States |
OSI Pharmaceuticals, Inc. Rankings
Executives
| 29 executives listed for OSI Pharmaceuticals, Inc.'s Melville, NY location. | ||
| Chairman | Robert Ingram | |
|---|---|---|
| EVP, CFO, and Treasurer | Pierre Legault | |
| EVP Pharmaceutical Development and Manufacturing | RobertSimon | |
Financials
| Company Type | Subsidiary - NASDAQ: OSIP Headquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 535 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on OSI Pharmaceuticals, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
